Management of Immune Checkpoint Inhibitor Mediated Myocarditis

被引：0
作者：
Mudra, Sarah
Culver, Austin
Kumar, Ashwin
Yesilyaprak, Abdullah
Agrawal, Ankit
Dey, Amit K.
Rizk, Alexander
Li, Jason
Johnson, Adam
McGowan, Kevin
Majid, Muhammad
Njus, Meredith
Lawrence, Luke
Klein, Allan L.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Cardio-oncology;
D O I：
10.1161/circ.148.suppl_1.18997
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A18997
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Immune checkpoint inhibitor–associated myocarditisCase reports and a review of the literature
    T. E. Osinga
    S. F. Oosting
    P. van der Meer
    R. A. de Boer
    B. C. Kuenen
    A. Rutgers
    L. Bergmann
    T. H. Oude Munnink
    M. Jalving
    M. van Kruchten
    Netherlands Heart Journal, 2022, 30 : 295 - 301
  • [42] Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy
    Buehning, Florian
    Lerchner, Tobias
    Vogel, Julia
    Hendgen-Cotta, Ulrike B.
    Totzeck, Matthias
    Rassaf, Tienush
    Michel, Lars
    BASIC RESEARCH IN CARDIOLOGY, 2025, 120 (01) : 171 - 185
  • [43] Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge
    Frascaro, Federica
    Bianchi, Nicola
    Sanguettoli, Federico
    Marchini, Federico
    Meossi, Sofia
    Zanarelli, Luca
    Tonet, Elisabetta
    Serenelli, Matteo
    Guardigli, Gabriele
    Campo, Gianluca
    Calabro, Luana
    Pavasini, Rita
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [44] Diagnostic value of ROCK2 protein in immune checkpoint inhibitors-associated myocarditis
    Li, Caie
    Jin, Yucheng
    Ma, Jie
    Sun, Runmin
    Huang, Jiawang
    Qi, Yali
    Wang, Qiongying
    Yu, Jing
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 427
  • [45] Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy
    Delombaerde, D.
    Vervloet, D.
    Franssen, C.
    Croes, L.
    Gremonprez, F.
    Prenen, H.
    Peeters, M.
    Vulsteke, C.
    ESMO OPEN, 2021, 6 (04)
  • [46] Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events
    Poto, Remo
    Troiani, Teresa
    Criscuolo, Gjada
    Marone, Giancarlo
    Ciardiello, Fortunato
    Tocchetti, Carlo Gabriele
    Varricchi, Gilda
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] To Close or Not to Close: A Case of Multisystem Immune Checkpoint Inhibitor Toxicity and PFO
    Ropri, Ayesha
    Yoo, Jeanwoo
    El-Hajjar, Mohammad
    Sah, Anuraag
    Shkolnik, Boris
    Belov, Dmitri
    CIRCULATION, 2023, 148
  • [48] Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic review
    Tan, Sean
    Sivakumar, Seiyon
    Segelov, Eva
    Nicholls, Stephen J.
    Nelson, J.
    CANCER EPIDEMIOLOGY, 2023, 83
  • [49] New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
    Khunger, Arjun
    Battel, Lucas
    Wadhawan, Ashna
    More, Aditi
    Kapoor, Ankita
    Agrawal, Nikhil
    CURRENT ONCOLOGY REPORTS, 2020, 22 (07)
  • [50] Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review
    Man, Xiuyue
    Wang, Hong
    Chen, Chen.
    Cong, Xiaofeng
    Sun, Lemeng
    Sun, Xueru
    Chen, Chen
    Zhang, Jing
    Yang, Lei
    FRONTIERS IN IMMUNOLOGY, 2025, 16
12345